Shane J. Cross

1.8k total citations
31 papers, 842 citations indexed

About

Shane J. Cross is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Shane J. Cross has authored 31 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Epidemiology. Recurrent topics in Shane J. Cross's work include Hematopoietic Stem Cell Transplantation (7 papers), Pharmaceutical studies and practices (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Shane J. Cross is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Pharmaceutical studies and practices (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Shane J. Cross collaborates with scholars based in United States, United Kingdom and Spain. Shane J. Cross's co-authors include Kristine R. Crews, James M. Hoffman, Donald K. Baker, Mary V. Relling, Alejandro R. Molinelli, Brad Moriyama, Aniwaa Owusu Obeng, Teri E. Klein, Stuart A. Scott and John R. Wingard and has published in prestigious journals such as Blood, The Journal of Pediatrics and Emerging infectious diseases.

In The Last Decade

Shane J. Cross

28 papers receiving 821 citations

Peers

Countries citing papers authored by Shane J. Cross

Since Specialization

Citations

This map shows the geographic impact of Shane J. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane J. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane J. Cross more than expected).

Fields of papers citing papers by Shane J. Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane J. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane J. Cross. The network helps show where Shane J. Cross may publish in the future.

Co-authorship network of co-authors of Shane J. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Shane J. Cross. A scholar is included among the top collaborators of Shane J. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane J. Cross. Shane J. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of GFR estimation equations using creatinine, cystatin C, and their combination in pediatric hematology–oncology: no single equation is superior across subgroups 2025 ·Pediatric Nephrology ·Kelly‐Anne Phillips, Yilun Sun, Li Tang, (unknown), Shane J. Cross, Jennifer L. Pauley, John McCormick, Alejandro R. Molinelli, John J. Bissler, (unknown), Clinton F. Stewart	1
2	Donor-derived anti-HLA antibodies in a haploidentical hematopoietic cell transplant recipient shortly after transplant 2024 ·Human Immunology ·Akshay Sharma, Brandon M. Triplett, Liying Chi, Shane J. Cross, Yan Zheng, Paula Y. Arnold	1
3	Clinical Outcomes of Respiratory Syncytial Virus Infection Among Pediatric Immunocompromised Hosts 2024 ·Pediatric Blood & Cancer ·(unknown), Ronald H. Dallas, Jose Ferrolino, Matt Johnson, Kim Allison, Shane J. Cross, Randall T. Hayden, Asunción Mejías, Diego R. Hijano	2
4	Evaluation of Continuous Infusion Vancomycin in a Pediatric Hematology/Oncology Population 2024 ·The Pediatric Infectious Disease Journal ·(unknown), Shane J. Cross, (unknown), Diego R. Hijano, William L. Greene, Yilun Sun, Li Tang, Jennifer L. Pauley, (unknown), (unknown)	0
5	Association of Vitamin A and D Deficiencies with Infectious Outcomes in Children Undergoing Intensive Induction Therapy for Acute Lymphoblastic Leukemia 2024 ·The Journal of Pediatrics ·Rhiannon R. Penkert, Bart G. Jones, Li Tang, Yin Su, Sima Jeha, Jun J. Yang, (unknown), Jose Ferrolino, (unknown), Ching‐Hon Pui, Shane J. Cross, Julia L. Hurwitz, Joshua Wolf	2
6	SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study 2023 ·Frontiers in Oncology ·Diego R. Hijano, Jose Ferrolino, (unknown), (unknown), (unknown), Randall T. Hayden, Joshua Wolf, Ronald H. Dallas, William L. Greene, Julie Richardson, Hana Hakim, (unknown), Shane J. Cross	0
7	Healthcare-Associated Infections Caused by Mycolicibacterium neoaurum 2023 ·Emerging infectious diseases ·(unknown), Shane J. Cross, (unknown), Hiroto Inaba, (unknown), (unknown), Elisabeth E. Adderson	4
8	Human Astrovirus VA1 Encephalitis in Pediatric Patients With Cancer: Report of 2 Cases and Review of the Literature 2022 ·Journal of the Pediatric Infectious Diseases Society ·(unknown), (unknown), (unknown), Virginia Hargest, Stacey Schultz‐Cherry, Valerie Cortez, Shane J. Cross, Deborah Ward, Randall T. Hayden, Jeffrey E. Rubnitz, Ching‐Hon Pui, Raja B. Khan, Diego R. Hijano	10
9	The Aerogen® Solo Is an Alternative to the Small Particle Aerosol Generator (SPAG-2) for Administration of Inhaled Ribavirin 2020 ·Pharmaceutics ·Ronald H. Dallas, (unknown), (unknown), (unknown), Shane J. Cross, (unknown), Jessica N. Brazelton, Randall T. Hayden, Diego R. Hijano	8
10	Pharmacokinetics of alemtuzumab in pediatric patients undergoing ex vivo T-cell-depleted haploidentical hematopoietic cell transplantation 2020 ·Cancer Chemotherapy and Pharmacology ·Senthil Velan Bhoopalan, Shane J. Cross, John C. Panetta, Brandon M. Triplett	7
11	Managing local‐regional failure in children with high‐risk neuroblastoma: A single institution experience 2018 ·Pediatric Blood & Cancer ·(unknown), (unknown), Daniel V. Wakefield, Shane J. Cross, Mikhail Doubrovin, Barry L. Shulkin, Thomas E. Merchant, Andrew M. Davidoff, Wayne L. Furman, Matthew J. Krasin, Victor M. Santana, John T. Lucas	2
12	Haploidentical Donor Transplantation Using a Novel Clofarabine-containing Conditioning Regimen for Very High-risk Hematologic Malignant Neoplasms 2018 ·Journal of Pediatric Hematology/Oncology ·Akshay Sharma, Guolian Kang, Anusha Sunkara, Hiroto Inaba, Sima Jeha, Shane J. Cross, Terrence L. Geiger, Brandon M. Triplett	2
13	Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion 2015 ·Blood ·Brandon M. Triplett, (unknown), Guolian Kang, Shane J. Cross, Joseph Moen, Mari Dallas, Christine Hartford, William E. Janssen, Ping‐Yee Law, Ewelina Mamcarz, David Shook, Ashok Srinivasan, Randall T. Hayden, Wing Leung	1
14	Phase I Study of the Safety and Pharmacokinetics of Plerixafor in Children Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Leukemia 2014 ·Biology of Blood and Marrow Transplantation ·Ashok Srinivasan, John C. Panetta, Shane J. Cross, Asha Pillai, Brandon M. Triplett, David Shook, Mari Dallas, Christine Hartford, Anusha Sunkara, Guolian Kang, Jeffrey Jacobsen, John Choi, Wing Leung	10
15	Posaconazole Therapeutic Drug Monitoring in Pediatric Patients and Young Adults with Cancer 2013 ·Annals of Pharmacotherapy ·(unknown), Shane J. Cross, Kristine R. Crews, Patricia M. Flynn, James M. Hoffman, Katherine M. Knapp, Jennifer L. Pauley, Alejandro R. Molinelli, William L. Greene	49
16	Development and use of active clinical decision support for preemptive pharmacogenomics 2013 ·Journal of the American Medical Informatics Association ·Gillian C. Bell, Kristine R. Crews, Mark R. Wilkinson, Cyrine E. Haidar, J. Kevin Hicks, Donald K. Baker, Nancy M. Kornegay, Wenjian Yang, Shane J. Cross, Scott C. Howard, Robert R. Freimuth, William E. Evans, Ulrich Broeckel, Mary V. Relling, James M. Hoffman	159
17	Phase I Study of the Tolerability and Pharmacokinetics of Palifermin in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation 2012 ·Biology of Blood and Marrow Transplantation ·Ashok Srinivasan, Kimberly A. Kasow, Shane J. Cross, (unknown), Chong Wang, Deo Kumar Srivastava, Xiangjun Cai, John C. Panetta, Wing Leung	17
18	A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record 2012 ·Clinical Pharmacology & Therapeutics ·J. Kevin Hicks, Kristine R. Crews, James M. Hoffman, Nancy M. Kornegay, Mark R. Wilkinson, Rachel Lorier, Alexander J. Stoddard, Wenjian Yang, Colton Smith, Christian A. Fernandez, Shane J. Cross, Cyrine E. Haidar, Donald K. Baker, Scott C. Howard, William E. Evans, Ulrich Broeckel, Mary V. Relling	77
19	Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Shane J. Cross, John H. Rodman, Jane C. Lindsey, Brian L. Robbins, (unknown), Geoffrey J. Yuen, Lawrence J. D’Angelo	10
20	Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults 2008 ·Clinical Pharmacology & Therapeutics ·(unknown), Brian L. Robbins, Shane J. Cross, (unknown), (unknown), (unknown), (unknown), (unknown), C. Rosé, (unknown), (unknown), (unknown), Mina Nikanjam, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact